. 2019 May 29;14:118. doi: 10.1186/s13023-019-1080-y

Table 8.

Guidance statements for hip replacement, hip reconstruction and growth modulation surgery

Statement	Percentage consensus
Hip replacement can be considered in adult patients with MPS VI who exhibit hip pain, reduced walking and endurance related to hip disease, as well as abnormal radiographic findings Evidence Grade: D (limited published evidence)	100%
Hip reconstruction is not routinely indicated, but may be considered in paediatric patients with MPS VI who exhibit hip pain, reduced walking and endurance related to hip disease, as well as abnormal radiographic findings Evidence Grade: D (limited published evidence)	92%
Growth modulation surgery is recommended in patients with MPS VI who have signs of genu valgum and should be performed as early as possible during the period of growth Evidence Grade: D (limited published evidence)	87%

Statement

Percentage consensus

Hip replacement can be considered in adult patients with MPS VI who exhibit hip pain, reduced walking and endurance related to hip disease, as well as abnormal radiographic findings

Evidence Grade: D (limited published evidence)

100%

Hip reconstruction is not routinely indicated, but may be considered in paediatric patients with MPS VI who exhibit hip pain, reduced walking and endurance related to hip disease, as well as abnormal radiographic findings

Evidence Grade: D (limited published evidence)

92%

Growth modulation surgery is recommended in patients with MPS VI who have signs of genu valgum and should be performed as early as possible during the period of growth

Evidence Grade: D (limited published evidence)

87%